MiNK Therapeutics Inc.

NASDAQ: INKT · Real-Time Price · USD
7.14
0.04 (0.56%)
At close: May 23, 2025, 3:57 PM
7.09
-0.70%
After-hours: May 23, 2025, 04:15 PM EDT

MiNK Therapeutics Statistics

Share Statistics

MiNK Therapeutics has 3.99M shares outstanding. The number of shares has increased by 14.21% in one year.

Shares Outstanding 3.99M
Shares Change (YoY) 14.21%
Shares Change (QoQ) 0.29%
Owned by Institutions (%) 2.05%
Shares Floating n/a
Failed to Deliver (FTD) Shares 1,730
FTD / Avg. Volume 24.27%

Short Selling Information

The latest short interest is 22.92K, so 0.58% of the outstanding shares have been sold short.

Short Interest 22.92K
Short % of Shares Out 0.58%
Short % of Float 2.27%
Short Ratio (days to cover) 10.28

Valuation Ratios

The PE ratio is -2.44 and the forward PE ratio is -4.02. MiNK Therapeutics's PEG ratio is 0.

PE Ratio -2.44
Forward PE -4.02
PS Ratio 0
Forward PS 0.5
PB Ratio -1.34
P/FCF Ratio -2.75
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for MiNK Therapeutics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.72, with a Debt / Equity ratio of -0.25.

Current Ratio 0.72
Quick Ratio 0.72
Debt / Equity -0.25
Debt / EBITDA -0.47
Debt / FCF -0.52
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee n/a
Profits Per Employee $-468,904.43
Employee Count 23
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax -10.77B
Effective Tax Rate 99900%

Stock Price Statistics

The stock price has increased by -25.63% in the last 52 weeks. The beta is 0.16, so MiNK Therapeutics's price volatility has been higher than the market average.

Beta 0.16
52-Week Price Change -25.63%
50-Day Moving Average 7.88
200-Day Moving Average 7.81
Relative Strength Index (RSI) 44.43
Average Volume (20 Days) 7,128

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -10.65M
Net Income -10.78M
EBITDA -10.57M
EBIT -10.78M
Earnings Per Share (EPS) -285.82
Full Income Statement

Balance Sheet

The company has 4.58M in cash and 4.92M in debt, giving a net cash position of -347.57K.

Cash & Cash Equivalents 4.58M
Total Debt 4.92M
Net Cash -347.57K
Retained Earnings -144.18B
Total Assets 5.72M
Working Capital -1.97M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.56M and capital expenditures 0, giving a free cash flow of -9.56M.

Operating Cash Flow -9.56M
Capital Expenditures n/a
Free Cash Flow -9.56M
FCF Per Share -2.53
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

INKT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for INKT is $37.5, which is 425.2% higher than the current price. The consensus rating is "Buy".

Price Target $37.5
Price Target Difference 425.2%
Analyst Consensus Buy
Analyst Count 2
Stock Forecasts

Stock Splits

The last stock split was on Jan 28, 2025. It was a backward split with a ratio of 1:10.

Last Split Date Jan 28, 2025
Split Type backward
Split Ratio 1:10

Scores

Altman Z-Score -41.23
Piotroski F-Score 4